Position in NTRA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$977,220
+$511,244 QoQ
Shares Held
3,600
+54.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#66
of 210 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $14,326,853 across 14 Diagnostics & Research names. NTRA ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
21,103 | $3,166,083 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
4,545 | $2,406,986 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
4,000 | $2,005,440 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
2,735 | $1,439,813 | |
| 5 | TWST |
Twist Bioscience Corp
|
9,911 | $1,019,643 | |
| 6 | NTRA |
Natera, Inc.
This page
|
3,600 | $977,220 | |
| 7 | VCYT |
Veracyte, Inc.
|
12,699 | $745,812 | |
| 8 | GRAL |
GRAIL, Inc.
|
9,330 | $636,959 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $977,220 | 3,600 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $465,976 | 2,330 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $366,544 | 1,600 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $321,940 | 2,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $168,940 | 1,000 | Shares | Sole | 2025-08-28 | |
| No filing history on record for this holder in this stock. | ||||||